168
edits
Changes
Jump to navigation
Jump to search
Line 4:
Line 4: + +
no edit summary
The [[FDA]] prohibits three types of DTC about a prescription drug: (1) inadequate risk information about adverse effects, (2) misleading effectiveness claims, and (3) misleading comparative claims. In addition, the FDA particularly scrutinizes and disfavors the promotion of unapproved or "off-label" uses of prescription drugs.
The [[FDA]] prohibits three types of DTC about a prescription drug: (1) inadequate risk information about adverse effects, (2) misleading effectiveness claims, and (3) misleading comparative claims. In addition, the FDA particularly scrutinizes and disfavors the promotion of unapproved or "off-label" uses of prescription drugs.
Direct-to-consumer advertising of pharmcuticals is often regarded as giving patients false hope, and a mistaken impression that they are sufficiently informed to judge their own medical needs. Patients pressure their doctors to perscribe medication which may not be suitable for their condition. For this reason, many countries such as the United Kingdom ban direct-to-consumer pharmacutical advertising completly.